FINRA Reminds Firms of Their Obligations Regarding Transactions in OTC Equity Securities Quoted Pursuant to a Submitted Form 211
A member shall provide an associated person with the following written statement whenever the associated person is asked, pursuant to FINRA Rule 1010, to sign an initial or amended Form U4, or otherwise provide written (which may be electronic) acknowledgment of an amendment to the Form U4:
The Form U4 contains a predispute arbitration clause. It is in item 5 of Section 15A of the Form U4. You
(a) Call for Review by GovernorA Governor may call an eligibility proceeding for review by the FINRA Board if the call for review is made within the period prescribed in paragraph (b).(b) 15 Day Period; WaiverA Governor shall make his or her call for review not later than the next meeting of the FINRA Board that is at least 15 days after the date on which the FINRA Board receives the proposed
In an effort to communicate technical changes to its trade reporting and quotation facilities - TRACE, ORF, and ADF (and related systems) with FINRA member firms, FINRA is introducing a new web page, on FINRA.org, where firms may review upcoming market transparency initiatives. This page will be updated on a regular basis in addition to technical notices that will continue to be posted and
Effective January 1, 2008,1 Dual Member firms will not be required to disclose the name of the securities market on which the transaction was effected on confirmations or reports as required under NYSE Rule 409(f).
The Manipulative Trading topic of the 2024 FINRA Annual Regulatory Oversight Report (the Report) informs member firms’ compliance programs by providing annual insights from FINRA’s ongoing regulatory operations, including (1) regulatory obligations and related considerations, (2) findings and effective practices, and (3) additional resources.
I am writing to state my opposition to any new rules (Notice #22-08) which would restrict my ability as an individual investor to use many of the investment products available, including leveraged and inverse investment products. I believe that the job of FINRA should be to assure us that the products are soundly constructed and to insure that the risks associated with their use are adequately
I found it very alarming to hear that FINRA is considering restricting access to leveraged ETFs. It is very concerning to hear that regulators believe private investors are incapable of understanding the risks associated with a leveraged asset like the ones that I utilize in my investment strategy. These investments undoubtably are more complex than an individual stock, but it is my belief that
Members of FINRA,
Leveraged and inverse ETFs are of great importance to me
and I strongly object to any new restrictions on the usage of these investment vehicles.
I presume that the potential new rules are motivated by the beliefs that 1) these funds are excessively risky and 2) without the new rules, investors will not understand the risks. I dispute both premises. The risks are already
We, retail investors, should have the freedom to choose the right public investment tools. Some people's losses should not limit other people's usage, and our ordinary investors should not be punished accordingly. Also, we understand the leveraged and inverse funds and their risks. There are lots of publicly available materials online and disclosures. After all, if one invests
